4.6 Article

The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

Emerging role of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) as a key regulator of inflammatory responses

Adam Collison et al.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2009)

Article Urology & Nephrology

The effect of joint exposures: examining the presence of interaction

Renee de Mutsert et al.

KIDNEY INTERNATIONAL (2009)

Review Biochemistry & Molecular Biology

TRAIL and osteoprotegerin: a role in endothelial physiopathology?

Federica Corallini et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2008)

Article Immunology

CD8 T cells utilize TRAIL to control influenza virus infection

Erik L. Brincks et al.

JOURNAL OF IMMUNOLOGY (2008)

Article Biochemistry & Molecular Biology

Trail and vascular injury

Jose L. Martin-Ventura et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2007)

Article Transplantation

Association between phosphate removal and markers of bone turnover in haemodialysis patients

Marta Albalate et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)

Article Cardiac & Cardiovascular Systems

The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis

Y Michowitz et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)

Article Cardiac & Cardiovascular Systems

Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease

S Kiechl et al.

CIRCULATION (2004)

Article Urology & Nephrology

Goodpasture syndrome during the course of a Schonlein-Henoch purpura:

L Carreras et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2002)

Article Transplantation

The malnutrition, inflammation, and atherosclerosis (MIA) syndrome - the heart of the matter

R Pecoits et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)